Eudaemon Technologies Raises $4.5M Seed, Opens $10M Round

Eudaemon Technologies has raised a $4.5 million seed round and opened a further $10 million financing round, according to Pulse 2.0, to commercialize its hydrogel condom.

The two figures define the company's current position: $4.5 million banked, $10 million sought. The company makes condoms from hydrogel — a water-based polymer material — rather than traditional latex. Pulse 2.0 reports the capital will fund commercialization of the product.

The deal terms beyond the round sizes remain undisclosed. Pulse 2.0's report names neither the seed investors nor the lead backers of the new $10 million round. That gap matters: investor identity often signals how close a materials-science medical product sits to market entry.

What does the money buy?

Commercialization, not research, is the stated destination. For a condom built from hydrogel, that path typically runs through regulatory clearance and manufacturing scale-up, though Pulse 2.0 does not specify which stage the funds will cover first. The company has not publicly stated a timeline for market launch.

The $10 million round is now open, which means the total Eudaemon is targeting across both tranches is $14.5 million — roughly $4.5 million secured against $10 million still to be raised.

What is not said?

The report leaves key questions unanswered:

• No named investors in either round
• No valuation disclosed
• No launch date or target market specified
• No revenue figures, unsurprising for a pre-commercial company

Hydrogel condoms have drawn research interest for years as a latex alternative promising improved sensation. Whether Eudaemon's product clears regulatory review and reaches shelves is the question the $10 million round will help answer.

The open round, not the closed seed, is the number to watch: closing it signals investor confidence in the commercialization plan.